Zai Lab Completes Enrollment of China Pivotal Trial of Niraparib as Second-Line Maintenance Therapy for Ovarian Cancer in China - SC Read more about Zai Lab Completes Enrollment of China Pivotal Trial of Niraparib as Second-Line Maintenance Therapy for Ovarian Cancer in China - SC
Zai Lab to Present at the 37th Annual J.P. Morgan Healthcare Conference - SC Read more about Zai Lab to Present at the 37th Annual J.P. Morgan Healthcare Conference - SC
Zai Lab Limited Announces Presentations at November Conferences - SC Read more about Zai Lab Limited Announces Presentations at November Conferences - SC